Figure 1.
T-TAS parameters in patients with dual antiplatelet therapy and healthy blood donors.
Reference ranges for T-TAS were defined as 2.5%–97.5% percentiles of the healthy population.
Abbreviations: AUC-PL, area under the curve for the PL-chip; AUC-AR, area under the curve for the AR-chip; DAPT, dual antiplatelet therapy.